Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study

Lucio Malvisi, N. P. Williams(University Hospital Southampton NHS Foundation Trust), Béatrice Sente(GlaxoSmithKline (Belgium)), Johanna M. Jefferies(University Hospital Southampton NHS Foundation Trust), Karl J. Staples(University Hospital Southampton NHS Foundation Trust), Kristoffer Ostridge(Southampton General Hospital), Béatrice Sente(Solent NHS Trust), Rebecca Anderson(University of Southampton), Andrew Tuck(University of Southampton), Nathalie Devos(GlaxoSmithKline (Belgium)), Anthony P. Williams(University of Southampton), Karen L. Osman(Defence Science and Technology Laboratory), Jenna Alnajar(University of Southampton), Ngaire Coombs(University of Southampton), Jeanne‐Marie Devaster(GlaxoSmithKline (Belgium)), Lindsay Welch(GlaxoSmithKline (Belgium)), Elizabeth H. Dineen(University of California, Irvine), Rebecca A. Gladstone(Wellcome Sanger Institute), Simon Bourne(GlaxoSmithKline (Belgium)), Tim Elliott(University of Southampton), V. L. Kim(University Hospital Southampton NHS Foundation Trust), M. Caubet(GlaxoSmithKline (Belgium)), Vincent Weynants(GlaxoSmithKline (Belgium)), A. Barton(University of Southampton), Tom Wilkinson(University Hospital Southampton NHS Foundation Trust), Stuart C. Clarke(University Hospital Southampton NHS Foundation Trust), Vanessa T. Devine(University of Southampton), Sonia Schoonbroodt(University of Liège), Catherine Cohet(GlaxoSmithKline (Belgium)), Aparna Yarraguntla(GlaxoSmithKline (Belgium)), Laura Taddei, Emmanuel Aris(GlaxoSmithKline (Belgium)), Thierry Pascal(GlaxoSmithKline (Belgium)), Stephen Harden(University Hospital Southampton NHS Foundation Trust), Philippe Moris(GlaxoSmithKline (Belgium)), W R Ballou(GlaxoSmithKline (Belgium)), Marie-Cécile Mortier(GlaxoSmithKline (Belgium)), Mathieu Peeters(GlaxoSmithKline (Belgium)), David Cleary(University of Birmingham)
Scandinavian Journal of Infectious Diseases
July 6, 2022
Cited by 3


Related Papers